Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 08, 2021 8:01am

64 Views

Post# 32498537

market depth early morning

Special terms and non-boardlot orders do not appear in Depth by Price +Vertical +Columnar +Horizontal

V:VXL Depth by Order @08:00:10

Bid			Ask
Broker	Size	Price	Price	Size	Broker
79 CIBC	2,000	0.49	0.49	28,000	124 Questrade
7 TD Sec	1,200	0.49	0.49	8,000	124 Questrade
2 RBC	1,000	0.49	0.49	1,000	7 TD Sec
53 Morgan Stanley	1,000	0.49	0.49	523	7 TD Sec
53 Morgan Stanley	500	0.49	0.49	100,000	2 RBC
13 Instinet	21,000	0.48	0.50	17,000	2 RBC
80 National Bank	5,000	0.47	0.50	500	124 Questrade
80 National Bank	10,000	0.47	0.50	1,020	124 Questrade
88 Credential	2,000	0.47	0.50	4,000	124 Questrade
1 Anonymous	1,000	0.465	0.51	2,000	2 RBC